US$ 26.88
ipamorelin farmaco Research Peptide | Ipamorelin 5mg vivo procedures Ipamorelin (RUO) | Selective GHS-R1a
Description
LR3 IGF-I Human, E

284 MAT2A Methylthioadenosine phosphorylase (MTAP)-deficient tumors account for ~15% of solid tumors, including ~15% of NSCLC, 28% of esophageal cancer, 26% of bladder cancer, and 10% of esophagogastric cancer

[DOI] [PubMed] [Google Scholar] 87.Bennett CN, et al

doi: 10.1016/j.bbr.2016.10.010
